Q: Can you comment about this US drug Co. developing immuno-medicines for Cancer.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Hi Team,
Could you tell us why TTD has been up more than $35 in a week? I didn't see any news after the earnings report. Do you think it's still a good hold here or trim ?
Thanks!
Could you tell us why TTD has been up more than $35 in a week? I didn't see any news after the earnings report. Do you think it's still a good hold here or trim ?
Thanks!
Q: Hi 5i team,
Back to AMRN. I thought they hit a home run yesterday with a unanimous (16 to 0) vote of the Advisory Committee to approve an expanded label use of Vascepa for treating various heart-related conditions, which should give them access to a much larger patient population base. However, the market is not so sure as the response is very muted at least so far today, and that may change. I took a small position to manage risk as I expected a big move one way or the other. I recognize this still has to go to the full FDA in a few weeks, but I understand that the FDA seldom overturns a strong endorsement of the AdCom. Am I missing something here in the muted market response?
Thanks again.
Dave
Back to AMRN. I thought they hit a home run yesterday with a unanimous (16 to 0) vote of the Advisory Committee to approve an expanded label use of Vascepa for treating various heart-related conditions, which should give them access to a much larger patient population base. However, the market is not so sure as the response is very muted at least so far today, and that may change. I took a small position to manage risk as I expected a big move one way or the other. I recognize this still has to go to the full FDA in a few weeks, but I understand that the FDA seldom overturns a strong endorsement of the AdCom. Am I missing something here in the muted market response?
Thanks again.
Dave
Q: I see Lithium and related stocks have taken quite a beating as supply has overstripped demand. However long term growth in electric car and required batteries seems to bode well for the industry. Any lithium stocks you recommend at this time for a longer term hold? Prefer companies with production or close to versus speculative...
Q: What do you think of oxy as a dividend and growth company
Phil
Phil
-
Cisco Systems Inc. (CSCO $78.82)
-
Altria Group Inc. (MO $64.39)
-
Philip Morris International Inc (PM $163.24)
-
Total Energy Services Inc. (TOT $22.18)
Q: On the US side, we've owned TOT, CSCO, MO and PM for some time now and they have languished. Is patience merited or should I sell these positions and replace them with other US stocks? We're retired and want to preserve capital but do like dividend income. thanks
Q: Spruce Point Capital has issued a report against Cintas. Can you give any comment on the reputation of Spruce Point or how seriously we should take their report?
Q: Hi Guys
Could you guess what sleeping 5G co. will benefit from the roll out
Bob
Could you guess what sleeping 5G co. will benefit from the roll out
Bob
Q: Which company do you like better as a long term hold in an RRSP?
Q: Could you provide your opinion on PFPT Would you be comfortable buying at today's price? Thanks Claude
Q: Can you comment on the investment merits of CArlyle group?
Q: Disney is up a lot today. Is it still a buy or a hold at this point?
-
Raytheon Company (RTN $116.96)
-
The Rubicon Project Inc. (RUBI)
-
The Trade Desk Inc. (TTD $23.95)
-
Guardant Health Inc. (GH $84.96)
Q: Since starting to do more and more of my own investing I have found your advice incredibly profitable! Thank you. I follow the Canadian balanced portfolio and try to add in some US growth names. I am also diversified into ETFs. Right now I have cash for 2 new US positions. I want to add growth positions and have a long long time frame. Currently considering GH, RTN and RUBI. Do you still like all three at current prices? And which would you choose? Any other suggestions?
Q: What do you like of this company it had quite a drop recently I’m guessing earning had something to do with that .Would you buy this company
Thanks for the help
Thanks for the help
Q: Please give insight on the business model that CPSI follows. It just reported reasonable results. Hares gapped up for only a day before falling back down. This could be due profit taking in this thinly traded security. What insight please on :
1. MOAT
2.PEG
3. Debt (manageable?)
4. Sufficient insider ownership ? (Considering its tiny size and negative price history)
5. Price to free cash flow;
PLEASE any information (of *substance* ) you can provide from your expert sources would be very helpful.
I don't expect you to know whether or not this is a candidate for a buy out by a larger company. Nevertheless , do you think CPSI is a better than average candidate for a consolidator in its industry?
1. MOAT
2.PEG
3. Debt (manageable?)
4. Sufficient insider ownership ? (Considering its tiny size and negative price history)
5. Price to free cash flow;
PLEASE any information (of *substance* ) you can provide from your expert sources would be very helpful.
I don't expect you to know whether or not this is a candidate for a buy out by a larger company. Nevertheless , do you think CPSI is a better than average candidate for a consolidator in its industry?
Q: Hi, your thoughts on KNSL and LOB?
Q: Is there currently a stock that 5I considers a "screaming buy" in Canada or the US for a short or long term hold.
Thanks Valter
Thanks Valter
Q: Looking at the Reit space in the US and I have been watching this one for awhile. It has come off a fair bit since its high. Thoughts on their latest quarter and their business going forward.
cheers
cheers
Q: FDA apparently has positive views on AMARIN's new drug Vascepa so approval for broad use seems likely; hence the recent pop. How much more upside does the stock have in the medium term.
Thanks for your insight.
Ian
Thanks for your insight.
Ian
Q: Hi Group recently I have taken a hit on ZTS (poor quarter results + SYK (acquisition another company) I was up 15% + 20% respectively presently breaking even or slightly up > to date. Should I sell one or both or keep one or both and why ? thanks for your advise.